Cargando…

Biomarker-Oriented Therapy in Bladder and Renal Cancer

Treatment of patients with urothelial carcinoma (UC) of the bladder or renal cancer has changed significantly during recent years and efforts towards biomarker-directed therapy are being investigated. Immune checkpoint inhibition (ICI) or fibroblast growth factor receptor (FGFR) directed therapy are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scholtes, Mathijs P., Alberts, Arnout R., Iflé, Iris G., Verhagen, Paul C. M. S., van der Veldt, Astrid A. M., Zuiverloon, Tahlita C. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999814/ https://www.ncbi.nlm.nih.gov/pubmed/33799514 http://dx.doi.org/10.3390/ijms22062832

Ejemplares similares

Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy
por: Scholtes, Mathijs P., et al.
Publicado: (2021)

Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer
por: de Jong, Florus C., et al.
Publicado: (2021)

Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines
por: Zuiverloon, Tahlita C.M., et al.
Publicado: (2018)

Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer(1)
por: Tu, Megan M., et al.
Publicado: (2019)

In-depth investigation of the molecular pathogenesis of bladder cancer in a unique 26-year old patient with extensive multifocal disease: a case report
por: Zuiverloon, Tahlita CM, et al.
Publicado: (2010)

Open versus minimal invasive radical cystectomy
por: van Diepen, Danielle C., et al.
Publicado: (2020)

Artificial Intelligence in Digital Pathology for Bladder Cancer: Hype or Hope? A Systematic Review
por: Khoraminia, Farbod, et al.
Publicado: (2023)

Selection of Microsatellite Markers for Bladder Cancer Diagnosis without the Need for Corresponding Blood
por: van Tilborg, Angela A. G., et al.
Publicado: (2012)

A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA gene
por: Hurst, Carolyn D, et al.
Publicado: (2009)

Sewage surveillance system using urological wastewater: Key to COVID-19 monitoring?
por: de Jong, Florus C., et al.
Publicado: (2023)

Targeted therapies in renal cell cancer: recent developments in imaging
por: van der Veldt, Astrid A. M., et al.
Publicado: (2010)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections
por: van Puffelen, Jelmer H, et al.
Publicado: (2023)

Assessment of imaging biomarkers in the follow-up of brain metastases after SRS
por: Derks, Sophie H A E, et al.
Publicado: (2021)

Open Repair of Two Ipsilateral Extracranial Internal Carotid Artery Aneurysms
por: Iflé, Iris G., et al.
Publicado: (2020)

Advances in (177)Lu-PSMA and (225)Ac-PSMA Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer
por: Ling, Sui Wai, et al.
Publicado: (2022)

FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
por: Kompier, Lucie C., et al.
Publicado: (2010)

Multivariable risk-based patient selection for prostate biopsy in a primary health care setting: referral rate and biopsy results from a urology outpatient clinic
por: Osses, Daniël F., et al.
Publicado: (2018)

Positron Emission Tomography as a Method for Measuring Drug Delivery to Tumors in vivo: The Example of [(11)C]docetaxel
por: van der Veldt, Astrid A. M., et al.
Publicado: (2013)

Brain metastases: the role of clinical imaging
por: Derks, Sophie H. A. E., et al.
Publicado: (2022)

Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR
por: Dyrskjøt, L, et al.
Publicado: (2012)

Comment on Cho et al.: Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction
por: van der Veldt, Astrid A. M., et al.
Publicado: (2011)

Suitability of tumor-associated antibodies as predictive biomarker for response to immune checkpoint inhibitors in patients with melanoma: a short report
por: de Joode, Karlijn, et al.
Publicado: (2023)

Encouraging residents’ professional development and career planning: the role of a development-oriented performance assessment
por: Dijkhuizen, Kirsten, et al.
Publicado: (2018)

Reply: Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer
por: van der Veldt, A A M, et al.
Publicado: (2009)

Renal and Bladder Tuberculosis
por: Dowd, J. Henry
Publicado: (1902)

Acute renal failure following consumption of fish gall bladder
por: Bhattacharyya, P. C., et al.
Publicado: (2009)

Urinary Bladder Cancer: Biomarkers and Target Therapy, New Era for More Attention
por: Mohammed, Amrallah A., et al.
Publicado: (2016)

Can We ‘Read’ the Eye-Movement Patterns of Readers? Unraveling the Relationship Between Reading Profiles and Processing Strategies
por: Koornneef, Arnout, et al.
Publicado: (2016)

Biomarkers for Predicting Clinical Outcomes of Chemoradiation-Based Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
por: Koga, Fumitaka, et al.
Publicado: (2018)

Asymptomatic renal BCG granulomatosis: An unusual complication of intravesical BCG therapy for carcinoma urinary bladder
por: Bhat, Suresh, et al.
Publicado: (2015)

Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer
por: Schmidt, Bogdana, et al.
Publicado: (2022)

Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring
por: Lodewijk, Iris, et al.
Publicado: (2018)

Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
por: Martinez, Victor G., et al.
Publicado: (2019)

Distribution of Prostate Imaging Reporting and Data System score and diagnostic accuracy of magnetic resonance imaging–targeted biopsy: comparison of an Asian and European cohort
por: Zhang, Kai, et al.
Publicado: (2019)

Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib
por: van der Veldt, A A M, et al.
Publicado: (2010)

Conservative management of bladder endometriosis with acute renal failure
por: Xu, Mark C., et al.
Publicado: (2020)

Urinary MicroRNA as Biomarker in Renal Transplantation
por: van de Vrie, M., et al.
Publicado: (2016)

Circulating Biomarkers in Bladder Cancer
por: Nandagopal, Lakshminarayanan, et al.
Publicado: (2016)

Urinary biomarkers of overactive bladder
por: Tian, Xiao-Jun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pcm3ghkmvlm01dggj3m57haqui